These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1338933)

  • 1. [Ubiquitin and degenerative diseases of the central nervous system].
    Tranchant C; Muller S; Warter JM
    Rev Neurol (Paris); 1992; 148(12):731-5. PubMed ID: 1338933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases.
    Mayer RJ; Lowe J; Lennox G; Doherty F; Landon M
    Prog Clin Biol Res; 1989; 317():809-18. PubMed ID: 2557642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HSP 70 is associated with abnormal cytoplasmic inclusions characteristic of neurodegenerative diseases].
    Namba Y; Tomonaga M; Ohtsuka K; Oda M; Ikeda K
    No To Shinkei; 1991 Jan; 43(1):57-60. PubMed ID: 2054224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders.
    Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of protein ubiquitination in neurodegenerative disease.
    Mayer RJ; Lowe J; Landon M; McDermott H; László L
    Acta Biol Hung; 1991; 42(1-3):21-6. PubMed ID: 1668896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEDD8 protein is involved in ubiquitinated inclusion bodies.
    Dil Kuazi A; Kito K; Abe Y; Shin RW; Kamitani T; Ueda N
    J Pathol; 2003 Feb; 199(2):259-66. PubMed ID: 12533840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin: a multifunctional regulatory protein associated with the cytoskeleton.
    Fried VA; Smith HT
    Prog Clin Biol Res; 1989; 317():733-44. PubMed ID: 2557641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical Lewy bodies in Alzheimer's disease.
    Kazee AM; Han LY
    Arch Pathol Lab Med; 1995 May; 119(5):448-53. PubMed ID: 7748074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin immunochemistry as a diagnostic aid for community pathologists evaluating patients who have dementia.
    Chu CT; Caruso JL; Cummings TJ; Ervin J; Rosenberg C; Hulette CM
    Mod Pathol; 2000 Apr; 13(4):420-6. PubMed ID: 10786809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of ubiquitin immunohistochemistry to the diagnosis of disease.
    Lowe J; Hand N; Mayer RJ
    Methods Enzymol; 2005; 399():86-119. PubMed ID: 16338351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filaments of Lewy bodies contain insoluble cytoskeletal elements.
    Galloway PG; Mulvihill P; Perry G
    Am J Pathol; 1992 Apr; 140(4):809-22. PubMed ID: 1314025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of frontotemporal lobar degeneration with ubiquitin-positive intraneuronal inclusions.
    Leel-Ossy L; Révész T; Almási K; Szucs I; Szabó E
    Ideggyogy Sz; 2007 Jul; 60(7-8):330-5. PubMed ID: 17713114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathologic markers in degenerative dementias].
    Hauw JJ; Seilhean D; Colle MA; Hogenhuys J; Duyckaerts C
    Rev Neurol (Paris); 1998; 154 Suppl 2():S50-64. PubMed ID: 9834544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical appearance of complement protein, C4d, in the nervous system and its significance].
    Yamada T
    No To Shinkei; 1998 Feb; 50(2):137-45. PubMed ID: 9513203
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
    Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease.
    Lowe J; Blanchard A; Morrell K; Lennox G; Reynolds L; Billett M; Landon M; Mayer RJ
    J Pathol; 1988 May; 155(1):9-15. PubMed ID: 2837558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of the ubiquitin system in Alzheimer's disease (review).
    Pallares-Trujillo J; Lopez-Soriano FJ; Argilés JM
    Int J Mol Med; 1998 Jul; 2(1):3-15. PubMed ID: 9854137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.
    Gai WP; Yuan HX; Li XQ; Power JT; Blumbergs PC; Jensen PH
    Exp Neurol; 2000 Dec; 166(2):324-33. PubMed ID: 11085897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proteomic approach to assess intraneuronal inclusions associated with neurodegenerative disorders.
    Kawaja MD
    Curr Opin Mol Ther; 2005 Dec; 7(6):565-8. PubMed ID: 16370379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.